These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16715213)

  • 1. Metabolic effects of telmisartan in spontaneously hypertensive rats.
    Li YQ; Ji H; Zhang YH; Ding DY; Ye XL
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):264-70. PubMed ID: 16715213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation.
    Müller-Fielitz H; Landolt J; Heidbreder M; Werth S; Vogt FM; Jöhren O; Raasch W
    Endocrinology; 2012 Mar; 153(3):1103-15. PubMed ID: 22253423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
    Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension.
    Pravenec M; Landa V; Zídek V; Musilová A; Kazdová L; Qi N; Wang J; St Lezin E; Kurtz TW
    Physiol Res; 2003; 52(6):681-8. PubMed ID: 14640889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
    Liu W; Yamashita T; Kurata T; Kono S; Hishikawa N; Deguchi K; Zhai Y; Abe K
    Neurol Res; 2015 Jun; 37(6):491-501. PubMed ID: 25591419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone.
    Qi N; Kazdova L; Zidek V; Landa V; Kren V; Pershadsingh HA; Lezin ES; Abumrad NA; Pravenec M; Kurtz TW
    J Biol Chem; 2002 Dec; 277(50):48501-7. PubMed ID: 12384507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.
    Aitman TJ; Glazier AM; Wallace CA; Cooper LD; Norsworthy PJ; Wahid FN; Al-Majali KM; Trembling PM; Mann CJ; Shoulders CC; Graf D; St Lezin E; Kurtz TW; Kren V; Pravenec M; Ibrahimi A; Abumrad NA; Stanton LW; Scott J
    Nat Genet; 1999 Jan; 21(1):76-83. PubMed ID: 9916795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
    Seda O; Kazdova L; Krenova D; Kren V
    Physiol Genomics; 2003 Jan; 12(2):73-8. PubMed ID: 12429866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
    Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
    J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
    Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Cd36 gene play a key role in disturbed glucose and fatty acid metabolism in Prague hypertensive hypertriglyceridemic rats?
    Kadlecová M; Cejka J; Zicha J; Kunes J
    Physiol Res; 2004; 53(3):265-71. PubMed ID: 15209533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
    Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
    Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.
    Bähr IN; Tretter P; Krüger J; Stark RG; Schimkus J; Unger T; Kappert K; Scholze J; Parhofer KG; Kintscher U
    Hypertension; 2011 Oct; 58(4):725-32. PubMed ID: 21876071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
    Younis F; Oron Y; Limor R; Stern N; Rosenthal T
    Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
    Kono S; Kurata T; Sato K; Omote Y; Hishikawa N; Yamashita T; Deguchi K; Abe K
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):537-47. PubMed ID: 25534368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigation of Insulin Resistance by Mangiferin in a Rat Model of Fructose-Induced Metabolic Syndrome Is Associated with Modulation of CD36 Redistribution in the Skeletal Muscle.
    Zhou L; Pan Y; Chonan R; Batey R; Rong X; Yamahara J; Wang J; Li Y
    J Pharmacol Exp Ther; 2016 Jan; 356(1):74-84. PubMed ID: 26498906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion.
    Deguchi K; Kurata T; Fukui Y; Liu W; Yun Z; Omote Y; Sato K; Kono S; Hishikawa N; Yamashita T; Abe K
    J Stroke Cerebrovasc Dis; 2014; 23(10):2646-2653. PubMed ID: 25307428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
    Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.